Hot Pursuit     10-Aug-21
Glenmark Life rises after Polar Capital buys minor stake
Glenmark Life Sciences gained 3.68% to Rs 764 after Polar Capital Funds acquired 8.36 lakh equity shares of the company via bulk deal on Monday, 9 August 2021.
Polar Capital Funds – Healthcare Opportunities Fund bought 8,36,000 equity shares (or 0.68% stake) of Glenmark Life Sciences at an average price of Rs 732.55 per equity share via bulk deals on the NSE yesterday, 9 August 2021.

Glenmark Life Sciences is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease (CVS), central nervous system disease (CNS), pain management and diabetes. The company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas.

Shares of the drug company entered the bourses on 6 August 2021. The stock listed at price of Rs 751.10 per share, representing 4.32% premium to the issue price of Rs 720 per share. The initial public offer of the company received bids for 66.33 crore shares as against 1.50 crore shares on offer, according to stock exchange data. The issue was subscribed 44.17 times. The issue opened for bidding on 27 July 2021 and closed on 29 July 2021. The price band of the IPO was fixed at Rs 695-720 per share.

Glenmark Life Sciences reported a net profit of Rs 351.58 crore and sales of Rs 1,885.17 crore in the twelve months ended 31 March 2021.

Previous News
  Glenmark Life Sciences standalone net profit rises 11.10% in the September 2023 quarter
 ( Results - Announcements 20-Oct-23   13:51 )
  Glenmark Life Sciences standalone net profit rises 24.57% in the June 2023 quarter
 ( Results - Announcements 21-Jul-23   14:49 )
  Glenmark Life Sciences standalone net profit declines 33.08% in the March 2024 quarter
 ( Results - Announcements 25-Apr-24   15:45 )
  Glenmark Life Sciences announces board meeting date
 ( Corporate News - 15-Oct-22   10:10 )
  Glenmark Pharmaceuticals update on IPO of WOS Glenmark Life Sciences
 ( Corporate News - 03-Aug-21   21:03 )
  Glenmark Life spurts after Q4 PAT jumps 48% YoY to Rs 146 cr
 ( Hot Pursuit - 28-Apr-23   11:04 )
  Glenmark Life Sciences standalone net profit rises 7.75% in the June 2022 quarter
 ( Results - Announcements 05-Aug-22   08:22 )
  Glenmark Life Sciences fixes record date for interim dividend
 ( Market Beat - Reports 11-Nov-21   09:21 )
  Glenmark Life Sciences IPO subscribed 44.17 times
 ( IPO Centre - IPO News 29-Jul-21   18:03 )
  Volumes spurt at Glenmark Life Sciences Ltd counter
 ( Hot Pursuit - 06-Jun-22   14:30 )
  Glenmark Life Q1 PAT climbs 24% YoY to Rs 135 cr
 ( Hot Pursuit - 21-Jul-23   13:42 )
Other Stories
  NSE SME SAR Televenture's FPO subscribed 67%
  22-Jul-24   17:58
  Mahindra Logistics gains as Q1 net loss narrows to Rs 7.84 cr
  22-Jul-24   16:34
  IOB PAT rises 21% YoY to Rs 633 crore in Q1 FY25
  22-Jul-24   15:14
  Wipro Ltd leads losers in 'A' group
  22-Jul-24   15:00
  IDBI Bank gains as Q1 PAT climbs 40% YoY to Rs 1,719 cr
  22-Jul-24   14:51
  Remedium Lifecare Ltd leads losers in 'B' group
  22-Jul-24   14:45
  Volumes spurt at Chemplast Sanmar Ltd counter
  22-Jul-24   14:30
  NSE SME Prizor Viztech sizzles on debut
  22-Jul-24   14:05
  Energy shares fall
  22-Jul-24   14:00
  Real Estate stocks slide
  22-Jul-24   14:00
Back Top